Drug Approval | June 23, 2026
Teva submits FDA application for experimental Tourette syndrome treatment ecopipam
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
The session created a platform for meaningful discussions on the challenges of the disease and the importance of timely intervention
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
Initiative by National Health Authority aimed at accelerating automated claims processing under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
The mPTP plays a key role in mitochondrial dysfunction, inflammation, and neuronal death in neurodegenerative diseases
Shonan iPark was chosen for its globally connected life-science ecosystem, which unites pharmaceutical firms, next-generation medicine developers, AI and digital health innovators, venture capital, and academia
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
